News Releases
This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
05 11 2021 Eligibility for $0 out-of-pocket COVID-19 testing expanded to include adults and minors regardless of symptoms or suspected exposure, consistent with updated government guidance on insurance coverage for COVID-19 testingQuest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today unveiled several new enhancements to its COVID-19 testing services, with the goal to help...
-
05 11 2021 In the Largest Study of its Kind, Findings Highlight the Need to Increase Hepatitis C Testing and Treatment to Decrease Rates of Transmission, Morbidity, and MortalityA new Quest Diagnostics Health Trends® report developed in collaboration with the Centers for Disease Control and Prevention (CDC) found that the COVID-19 pandemic reduced routine hepatitis C...
-
05 03 2021 Ginkgo Bioworks Teams with Quest Diagnostics to Provide COVID-19 Testing for K-12 Schools NationwideCombines Ginkgo's robust Concentric by Ginkgo pooled testing program with Quest's PCR/NAAT COVID-19 pooled specimen testing to support return to classroomsGinkgo Bioworks ("Ginkgo") today announced a collaboration with Quest Diagnostics (NYSE:DGX) to provide COVID-19 Kindergarten through Senior (K-12) school testing services to support classroom...
-
04 27 2021 Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the BofA Securities 2021 Virtual Healthcare...
-
04 22 2021 -- First quarter revenues of $2.72 billion, up 49.3% from 2020Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended March 31, 2021. "Quest...